Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma

Abstract Background Current standard of treatment for newly diagnosed patients with glioblastoma (GBM) is surgical resection with adjuvant normofractionated radiotherapy (NFRT) combined with temozolomide (TMZ) chemotherapy. Hyperfractionated accelerated radiotherapy (HFRT) which was known as an opti...

Full description

Bibliographic Details
Main Authors: Victor Lewitzki, Rainer J. Klement, Rebekka Kosmala, Dominik Lisowski, Michael Flentje, Bülent Polat
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Radiation Oncology
Subjects:
Brain cancer
Glioblastoma
High grade glioma
Radiotherapy
Temozolomide
Corticosteroids
Online Access:https://doi.org/10.1186/s13014-019-1427-5

Internet

https://doi.org/10.1186/s13014-019-1427-5

Similar Items